CD274 and ovarian cancer: Enhanced surface expression of MHC-class I in ovarian cancer also correlates with increased numbers of tumor-infiltrating lymphocytes, improved response to PD1/PDL1 therapy, better prognosis, and prolonged life of cancer patients [106,107,109,110].